+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07188480

Evaluating DNA and RNA from Extracellular Vesicles in Bronchial Lavage for Genetic Testing in Advanced Non-Small Cell Lung Cancer Patients

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-09-23

10

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating a new method to analyze genetic material from patients with advanced non-small cell lung cancer NSCLC. The study focuses on using extracellular vesicles EVs found in bronchoalveolar lavage BAL fluid to perform Next Generation Sequencing NGS analyses. This is important because lung tumors can be difficult to sample with traditional biopsy techniques, especially when located in small or hard-to-reach areas, and repeated biopsies may be needed to identify drug resistance mechanisms. The study involves collecting fluid samples via bronchoalveolar lavage during bronchoscopy, then isolating EVs from the fluid to analyze their DNA and RNA using NGS. These EVs carry genetic material protected by a lipid layer, making them easier to amplify and potentially more reflective of the tumors genetic makeup than traditional blood-based liquid biopsies. Participants will undergo standard cytological sampling, and EV-DNARNA will be analyzed alongside these samples to compare results. Participants will have bronchoscopy performed as part of their clinical care, with additional analysis on the BAL fluid for EV isolation. The study will assess the adequacy of EV samples for NGS and measure the sensitivity and specificity of EV-based NGS compared to cytological samples. Laboratory analyses include nanoparticle tracking, flow cytometry, and protein marker evaluation. The study aims to provide less invasive methods for genetic testing in advanced NSCLC patients, improving diagnostic and treatment decisions over up to one year of follow-up.

CONDITIONS

Brief Title

The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients

Research Team

G

Gian Piero Bandelli, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here